TY - JOUR JO - EuroIntervention TI - Bivalirudin versus unfractionated heparin in percutaneous coronary interventions of patients having received initial fondaparinux treatment: a propensity matched study AB - <p class="text-1er-paragraph"><span class="appel-table-et-figure">Aims:</span> Fondaparinux is an indirect, Factor Xa inhibitor that requires co-administration of another anticoagulant with anti-Factor IIa activity for percutaneous coronary intervention ( AU - Hamon Martial AU - Rao Sunil V. AU - Steg P. Gabriel AU - Valgimigli Marco AU - Verheugt W.A. Freek AU - Marso Steven AU - Gershlick H. Anthony AU - Wang Yamei AU - Deliargyris Efthymios N. VL - 8 IS - 4 Y1 - 24/08/2012 Y1 - 2012 DOI - 10.4244/EIJV8I4A76 SP - 486 EP - 492 KW - pci KW - antithrombotic KW - acs KW - fondaparinux KW - bivalirudin KW - anti-thrombin PB - Europa Digital & Publishing SE - Clinical research UR - https://eurointervention.pcronline.com/article/bivalirudin-versus-unfractionated-heparin-in-percutaneous-coronary-interventions-of-patients-having-received-initial-fondaparinux-treatment-a-propensity-matched-study SN - 1774-024X ER -